Trial intelligence / Profile preview

PK Interactions of AEGR-733 with Lipid-Lowering Therapies in Healthy Volunteers

NCT00359281Phase 2Completed

Sponsor
Aegerion Pharmaceuticals
Start
Mar 2006
Primary completion
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lomitapide in hypercholesterolemia, sponsored by Aegerion Pharmaceuticals. Started Mar 2006; status: completed.

02

Drugs

lomitapide
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00359281.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00359281.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call